Secondary Logo

Recurrent miscarriage

Are NK cell subsets a good predictor?

Yeh, Chang-Chinga,b; Horng, Huann-Chenga,b; Wang, Peng-Huia,b,c,d,*

Journal of the Chinese Medical Association: May 2019 - Volume 82 - Issue 5 - p 443
doi: 10.1097/JCMA.0000000000000097
Letter to the Editor
Open

aDepartment of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC

bDepartment of Obstetrics and Gynecology, National Yang-Ming University, Taipei, Taiwan, ROC

cInstitute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan, ROC

dDepartment of Medical Research, China Medical University Hospital, Taichung, Taiwan, ROC

Received January 4, 2019; accepted January 4, 2019.

Conflicts of interest: The authors declare that they have no conflicts of interest related to the subject matter or materials discussed in this article.

Address correspondence. Dr. Peng-Hui Wang, Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, 201, Section 2, Shi-Pai Road, Taipei 112, Taiwan, ROC. E-mail addresses: phwang@vghtpe.gov.tw; pongpongwang@gmail.com; or phwang@ym.edu.tw (P.-H. Wang).

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recurrent pregnancy loss, recurrent miscarriage, and recurrent implantation failure, regardless of what the terminology is used, is a very challenging and frustrating condition for both the clinicians and patients attempting to reproduce.1,2 From a clinical viewpoint and patients’ wishes, physicians always have to deal with stressed couples who are frequently overwhelmed by the above-mentioned situation. Since there are many underlying causes (abnormal chromosomes, endocrinological disorders, and uterine abnormalities) and some are uncertain (immunological problems such as autoimmune antibodies, anti-phospholipid syndrome, thrombophilias, hemonatural killer cells, regulatory T cells, tumor necrosis factor α, cell-derived microparticles, leptin, certain glycoproteins, and cytokines) contributing to the recurrent pregnancy loss,3,4 any attempt to clarify the cause of recurrent miscarriage is welcome. We are happy to learn Dr. Adib Rad’s article, which has been published in the December issue of the Journal of the Chinese Medical Association last year to investigate the alternation of the natural killer (NK) cell subsets and cytokines on the impact of recurrent miscarriage.5 The authors used a case-control study to explore the potential markers such as NK cell subsets and cytokines (interleukin [IL]-2 and IL-12) in the prediction of the women who might have a higher risk of recurrent miscarriage.5 The authors found that an increased percentage of either CD56+CD16+ (a cut-off value of ≥ 5.25%) or CD56+CD16 (≥3.4%) cells in the peripheral blood was found in the women with recurrent miscarriage and claimed that their findings can be used to establish prospective researches to recognize the predictive value of these parameters in the evaluation of women with recurrent miscarriage.5 We congratulated the success and excellent works from the authors. However, some questions are raised and we hope to receive the authors’ response.

In the “Results” section (page 1068),5 the authors wrote that “the mean of living child in the control group and abortion in the case group was 1.45 ± 0.50 and 2.75 ± 1.01, respectively (p = 0.0001)”.5 What did the authors mean? Did the authors mean that women in the control group had delivered a mean of 1.45 living babies (parous 1.45) and women in the recurrent miscarriage group had abortion with a mean of 2.75?

In the “Methods” section (page 1066), why the authors decide to obtain the peripheral blood samples from all women at their follicular phases of the menstrual cycles? We are wondering why the authors did not perform this examination in the mid-luteal phase of the menstrual cycle between day 7 and day 10 after the mid-cycle luteinized hormone surge, which is well-known for the occurrence of implantation.3 It is well-known that NK cells varied during the menstrual cycles.

Finally, recurrent miscarriage women have been reported to show up-regulated cytotoxic NK cells that are suspected to play a causal role in abortion. According to the findings of the authors, can the increased percentage of CD56+CD16+ (≥5.25%) or CD56+CD16 (≥3.4%) cells be a representative of the up-regulated cytotoxic NK cells?

Back to Top | Article Outline

ACKNOWLEDGMENTS

This study was supported by grants from the Ministry of Science and Technology, Executive Yuan, Taiwan (MOST106-2314-B-075-061-MY3), and Taipei Veterans General Hospital (V108C-085).

Back to Top | Article Outline

REFERENCES

1. Hashemi M, Mokhtari M, Khazaeian S, Bahari G, Rezaei M, Nakhaee A, et al. Evaluation of HLA-G 14-bp ins/del and +3142G>C polymorphisms with susceptibility to recurrent spontaneous abortion.Taiwan J Obstet Gynecol201756276–80
2. Homer HA. Modern management of recurrent miscarriage.Aust N Z J Obstet Gynaecol20195936–44
3. Kuon RJ, Vomstein K, Weber M, Müller F, Seitz C, Wallwiener S, et al. The “killer cell story” in recurrent miscarriage: association between activated peripheral lymphocytes and uterine natural killer cells.J Reprod Immunol20171199–14
4. Seshadri S, Sunkara SK. Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis.Hum Reprod Update201420429–38
5. Adib Rad H, Basirat Z, Mostafazadeh A, Faramarzi M, Bijani A, Nouri HR, et al. Evaluation of peripheral blood NK cell subsets and cytokines in unexplained recurrent miscarriage.J Chin Med Assoc2018811065–70
© 2019 by Lippincott Williams & Wilkins, Inc.